Cell News and Research

RSS

Mapping the mysteries: Study reveals surprising hubs of human immune cells

Researchers in Israel comprehensively mapped the distribution and mass of primary immune cells across human tissues. This groundbreaking study, using advanced biotechnological methods, provides insights into the immune system's cellular network, challenging existing notions and emphasizing the bone marrow, lymph nodes, and spleen as primary immune cell reservoirs.

24 Oct 2023

Gene therapy breakthrough: Scientists develop method to deliver larger genes to target cells

Gene therapy currently represents the most promising approach for the treatment of hereditary diseases. Yet despite significant breakthroughs in recent years, there are still a number of hurdles that hinder the wider application of gene therapies.

24 Oct 2023

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Researchers from The Hospital for Sick Children (SickKids), the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) have demonstrated that by analyzing patients' blood samples, they are able to detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with an almost 100 percent life-time risk of developing cancer.

24 Oct 2023

Biofilm probiotic effective in preventing necrotizing enterocolitis in piglet model

Necrotizing enterocolitis (NEC) is a debilitating and deadly condition that affects infants who were born preterm.

24 Oct 2023

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously treated with immune checkpoint inhibitors and anti-angiogenic therapies compared with everolimus in a phase 3 clinical trial.

24 Oct 2023

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.

24 Oct 2023

New consortium to build on breakthroughs in malaria research to develop P. vivax vaccines

Plasmodium vivax is the most widespread human malaria-causing pathogen with 2.5 billion people living at risk in Africa, South America, Oceania, and Asia.

24 Oct 2023

Finding and targeting dormant tumor cells to prevent breast cancer recurrence

While breast cancer survival continues to improve, thanks to advances in detection and treatment, when breast cancer recurs – or returns after initial treatment – it is incurable.

24 Oct 2023

Research suggests shorter isolation periods for children with COVID-19

School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.

24 Oct 2023

Researchers discover new way to trigger programmed cell death in cancer cells

A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die.

24 Oct 2023

Study reveals unexpected role of pulmonary ionocytes in lung function

A new study by University of Iowa researchers finds that rare lung cells known as pulmonary ionocytes facilitate the absorption of water and salt from the airway surface.

24 Oct 2023

New insights into the molecular basis of schizophrenia during early brain development

Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated.

24 Oct 2023

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new "pseudo cell" formulation based on self-healing microcapsule-loading exosomes to treat diverse vitreoretinal diseases.

24 Oct 2023

Cell News and Research

Mapping the mysteries: Study reveals surprising hubs of human immune cells

Gene therapy breakthrough: Scientists develop method to deliver larger genes to target cells

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Biofilm probiotic effective in preventing necrotizing enterocolitis in piglet model

HIF-2α inhibitor belzutifan significantly reduces progression of clear cell renal cell carcinoma

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

New consortium to build on breakthroughs in malaria research to develop P. vivax vaccines

Finding and targeting dormant tumor cells to prevent breast cancer recurrence

Research suggests shorter isolation periods for children with COVID-19

Researchers discover new way to trigger programmed cell death in cancer cells

Study reveals unexpected role of pulmonary ionocytes in lung function

New insights into the molecular basis of schizophrenia during early brain development

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Study reveals an alternate origin of brain mosaicism in some children with focal epilepsy

Revolutionary approach links protein analysis and single-cell study to uncover disease mechanisms

Utilizing Biomarkers in Cancer Prevention, Diagnosis, and Treatment

Apoptotic cells play key role in hair follicle regression

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

Resistant potato starch usage found to be feasible and safe for hematopoietic stem cell transplantation patients

DeNovix CellDrop becomes first ACT® label certified automated cell counter

Improve fermentation and cell culture performance with real-time gas analysis eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo